<?xml version="1.0" encoding="UTF-8"?>
<fig id="cells-08-01338-f004" orientation="portrait" position="float">
 <label>Figure 4</label>
 <caption>
  <p>ZIKV provides a protection against intrinsically induced cell death by etoposide. (
   <bold>A</bold>) A549 cells were infected with BR15
   <sup>MC</sup> at MOI of 1 for 8 h and treated with etoposide 2 h before infection (2 hbi) or 2 h post infection (2 hpi). The percentage of A549 cells immunostained with anti-BAX antibody was followed. (
   <bold>B</bold>) A549 cells were infected with PF13 at MOI of 1 for 8 h and treated with etoposide for 16 h, 2 hpi. The percentage of A549 cells immunostained with anti-BAX antibody was followed. Values represent the mean and standard deviation of three independent experiments Data were analyzed by a one-way ANOVA test with post-hoc Tukeyâ€™s test (*** 
   <italic>p</italic> &lt; 0.001, **** 
   <italic>p</italic> &lt; 0.0001, ns = not significant).
  </p>
 </caption>
 <graphic xlink:href="cells-08-01338-g004" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
